Evidence-gap map · non-drug interventions

Prostate Cancer evidence gaps

305 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Prostate Cancer, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

305registered non-drug trials
36with results posted
108recruiting as of 2026-11-16
94group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition. The registry search returned 2,475 trials, more than the 1,000-trial cap, so this map covers the most recently updated 1,000.

none1–23–910–2930 or more
Registered non-drug trials for Prostate Cancer by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (67)91 with results·3101 with results41 with results·153 with results51 with results1992 with results1171 with results51 with results171 with results10
Rehabilitation and therapy services (13)·········5··2·63
Breathing and respiratory training (3)···1········2··1
Mind-body and psychological approaches (34)3·2103·221 with results·422211 with results1051 with results
Cognitive training and education (52)11 with results··71142·52 with results4455141 with results234 with results
Diet, fasting and nutrition (32)3·122·21·1102 with results71 with results22111 with results5
Sleep and circadian approaches (1)··············1·
Neuromodulation and electrical stimulation (4)····2······2·1··
Oxygen, light, temperature and manual therapies (21)2·1·2······25165
Supplements and nutraceuticals (46)··21······3197 with results31 with results64 with results81 with results124 with results
Other devices and digital tools (4)11 with results···1····11 with results·1···2
Care delivery and health services (15)···3·····1·1·1751 with results
Other behavioural, not yet classified (61)32 with results·21 with results132 with results21 with results141 with results2·61 with results42 with results63 with results91 with results817121 with results

The table scrolls sideways: 16 outcome columns.

Where the gaps are

This condition has 2,475 matching trials, more than the 1,000 this map covers, so it cannot show that an outcome was never measured. Only studied-but-unreported questions are listed.

Questions studied but with no results posted

  • Exercise and physical activity × inflammation and other biomarkers: 11 trials registered, none with results posted (4 still recruiting)
  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 10 trials registered, none with results posted (2 still recruiting)
  • Mind-body and psychological approaches × feasibility, adherence and safety: 10 trials registered, none with results posted (4 still recruiting)
  • Exercise and physical activity × quality of life: 9 trials registered, none with results posted (2 still recruiting)
  • Cognitive training and education × mood, anxiety and wellbeing: 7 trials registered, none with results posted (1 still recruiting)
  • Care delivery and health services × feasibility, adherence and safety: 7 trials registered, none with results posted (3 still recruiting)
  • Rehabilitation and therapy services × feasibility, adherence and safety: 6 trials registered, none with results posted (2 still recruiting)
  • Oxygen, light, temperature and manual therapies × feasibility, adherence and safety: 6 trials registered, none with results posted (2 still recruiting)
  • Rehabilitation and therapy services × quality of life: 5 trials registered, none with results posted (3 still recruiting)
  • Cognitive training and education × symptom severity and disease activity: 5 trials registered, none with results posted (1 still recruiting)
  • Cognitive training and education × clinical events, survival and healthcare use: 5 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 5 trials registered, none with results posted (4 still recruiting)
  • Mind-body and psychological approaches × quality of life: 4 trials registered, none with results posted
  • Cognitive training and education × physical function and exercise capacity: 4 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Prostate Cancer

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 71 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.